Algorithm


graph TD

classDef start fill:#1b5e20,color:#ffffff,stroke:#66bb6a;
classDef step fill:#0d47a1,color:#ffffff,stroke:#42a5f5;
classDef decision fill:#4a148c,color:#ffffff,stroke:#ab47bc;
classDef alert fill:#b71c1c,color:#ffffff,stroke:#ef5350;

A(<b>Cold Exposure</b><br>Initial Assessment):::start
B{<b>Injury Category</b>}:::decision

A --> B

B -->|Systemic| C[<b>Accidental Hypothermia</b><br>Core temp under 35C]:::step
B -->|Localized| D[<b>Soft Tissue Injury</b><br>Extremities and exposed skin]:::step
B -->|Recurrent| E[<b>Genetic Syndromes</b><br>Investigate for auto-inflammation]:::step

C --> F{<b>Clinical Stage</b>}:::decision

F -->|Mild 32 to 35C| G[<b>Mild Hypothermia</b><br>Shivering intact]:::alert
F -->|Mod 28 to 32C| H[<b>Moderate Hypothermia</b><br>Stupor and decreased pulse]:::alert
F -->|Severe Under 28C| I[<b>Severe Hypothermia</b><br>Coma and bradycardia]:::alert

G --> M[<b>Passive Rewarming</b><br>Remove wet clothes and insulate]:::step
H --> N[<b>Active Rewarming</b><br>Forced air and warmed IV fluids]:::step
I --> O[<b>Internal Rewarming</b><br>Check pulse 1 min and warm blood]:::step

D --> J{<b>Tissue Status</b>}:::decision

J -->|Freezing| K[<b>Frostbite I to IV</b><br>Ice crystal formation]:::alert
J -->|Non Freezing| L[<b>Frostnip or Chilblains</b><br>Edema and no necrosis]:::alert

K --> P[<b>Rapid Rewarming</b><br>Circulating bath 37 to 39C]:::step
L --> Q[<b>Conservative Mgmt</b><br>Rewarm and topical creams]:::step

General Principles

  • Occurs when physiological heat generation fails to overcome environmental heat loss.
  • Develops even at temperatures above 0°C.
  • Heat transfers to environment via radiation, conduction, convection, respiration, and evaporation.
  • Categorized broadly into systemic injuries (accidental hypothermia) and localized soft tissue injuries (freezing and non-freezing).

Systemic Injury: Accidental Hypothermia

Definition And Pathophysiology

  • Defined as unintentional core body temperature drop below 35°C.
  • Cerebral function diminishes at 33-34°C.
  • Early manifestations include irritability, confusion, and poor decision-making.
  • Progresses to lethargy, somnolence, and coma.

Clinical Staging And Characteristics

StateCore TemperatureClinical Characteristics
Mild32-35°CIncreased shivering thermogenesis; increased metabolic rate; amnesia and dysarthria; ataxia; apathy; normal blood pressure.
Moderate28-32°CStupor; 25% decrease in oxygen consumption; decreased shivering thermogenesis; atrial fibrillation and other dysrhythmias; pulse and cardiac output reduced to two-thirds normal.
Severe<28°CComa with loss of cerebrovascular autoregulation; severe bradycardia; hypotension; high risk of unstable tachycardias (ventricular fibrillation) and asystole.

Emergency Management

General Measures

  • Handle gently and keep horizontal to prevent cardiovascular collapse.
  • Remove wet clothing immediately.
  • Replace with dry clothing and insulation to halt heat loss.

Mild Hypothermia Management (32-35°C)

  • Initiate passive rewarming using insulation and vapor barriers.
  • Provide active external rewarming with heat packs applied to neck, chest, upper torso, axilla, and groin.
  • Protect exposed skin from direct burns.
  • Support shivering with high-calorie oral fluids and carbohydrates if child remains alert.

Moderate Hypothermia Management (28-32°C)

  • Deploy active external rewarming to upper torso, chest, axilla, and back utilizing forced-air systems or large heat pads.
  • Administer intravenous or intraosseous fluids containing glucose, warmed to 40-42°C.
  • Maintain continuous cardiac monitoring due to high risk of unstable arrhythmias from cold heart and acidosis.
  • Transfer hemodynamically unstable patients to facilities capable of extracorporeal membrane oxygenation.

Severe Hypothermia (<28°C) And Cardiac Arrest

  • Assess pulse for up to 1 minute before initiating cardiopulmonary resuscitation.
  • Utilize bedside echocardiogram to detect organized electrical activity.
  • Initiate cardiopulmonary resuscitation for absent cardiac activity.
  • Never withhold cardiopulmonary resuscitation based on temperature unless fatal injury exists or chest compression proves impossible.
  • Hold vasoactive medications until core temperature exceeds 30°C.
  • Administer vasoactive medications at twice normal dosing interval between 30°C and 35°C.
  • Attempt single defibrillation or cardioversion at maximum power.
  • Hold further electrical shocks until core temperature exceeds 30°C.
  • Initiate active internal rewarming via warm intravenous fluids, extracorporeal blood warming, or hemodialysis alongside extracorporeal membrane oxygenation.

Localized Soft Tissue Cold Injuries

Freezing Cold Injury: Frostbite

Pathogenesis

  • Occurs at or below freezing temperatures.
  • Progresses through four phases: prefreeze, freeze-thaw, vascular stasis, and late ischemic.
  • Cellular destruction results from intracellular and extracellular ice crystal formation during freeze-thaw phase.
  • Exacerbated by ischemic-reperfusion injury and microvascular thrombosis.

Clinical Grading Of Frostbite

GradeField ClassificationClinical Features
Grade ISuperficialSuperficial injury; edema and redness without necrosis; numbness; firm white-yellow plaque; no blisters.
Grade IISuperficialSubstantial edema and erythema; clear or milky fluid-filled vesicles and blisters; desquamation forms black eschar.
Grade IIIDeepExtends into dermis and vascular plexus; hemorrhagic deeper blisters; blue-gray discoloration; skin necrosis.
Grade IVDeepFull-thickness freezing of skin, subcutaneous tissue, muscle, tendon, and bone; little edema; mottled red progressing to dry, black, mummified tissue; requires amputation.

Management Of Frostbite

  • Protect injured area from cold exposure.
  • Remove constricting items including jewelry.
  • Strictly prevent refreezing if spontaneous thawing commences.
  • Initiate rapid rewarming using circulating water bath heated to 37-39°C for 30 minutes.
  • Leave clear blisters intact.
  • Never aspirate hemorrhagic bullae.
  • Administer pain control medications.
  • Ensure updated tetanus prophylaxis.
  • Consider adjuvant therapies for severe cases 12-72 hours post-thawing.
  • Adjuvant options include vasodilators, antiplatelet drugs, synthetic prostacyclin analogues, or intra-arterial tissue plasminogen activator.

Non-Freezing Cold Injuries

Frostnip

  • Associated with vasoconstriction and superficial ice crystal formation.
  • Presents with localized numbness and pallor.
  • Lacks cellular damage.
  • Resolves rapidly upon external warming.

Chilblains (Pernio)

right

  • Idiopathic condition triggered by cold, damp exposure.
  • Presents as painful, edematous, bluish-red papular or nodular lesions.
  • Affects acral locations including fingers, toes, and ears.
  • Management requires rewarming, cold avoidance, nonsteroidal anti-inflammatory drugs, and topical soothing creams.

Cold-Induced Fat Necrosis

  • Results from local cold injury to superficial adipose tissue.
  • Presents as raised, erythematous nodules or plaques.
  • Appears on face or exposed areas in obese children.
  • Follows self-limiting course resolving in 10-20 days.
  • Managed conservatively with rewarming and nonsteroidal anti-inflammatory drugs.

Differential Diagnosis: Genetic And Autoinflammatory Syndromes

  • Evaluate children presenting with recurrent cold-induced symptoms very early in life.
  • Suspect underlying genetics when rashes, fevers, and arthralgias occur without infectious triggers.

Familial Cold Autoinflammatory Syndrome

  • Represents part of cryopyrin-associated periodic syndromes.
  • Caused by variants in NLRP3 gene.
  • Triggered exclusively by cold exposure.
  • Manifests with nonpruritic urticaria, fever, conjunctivitis, and joint pain.

Familial Chilblain Lupus

  • Inherited as autosomal dominant disorder.
  • Caused by variants in TREX1 or SAMHD1 genes.
  • Presents with painful, bluish-red acral lesions resembling chilblains.
  • Provoked by environmental cold exposure.

Crisponi Syndrome / Cold-Induced Sweating Syndrome

  • Inherited as autosomal recessive disorder.
  • Linked to CRLF1 or CLCF1 gene variants.
  • Presents with cold-induced profuse sweating.
  • Associated with feeding difficulties and facial dysmorphic features.